O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.61%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11B
AUM Growth
+$11B
(+12%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
40.32%
Holding
136
New
6
Increased
34
Reduced
26
Closed
7
Top Buys
| 1 |
Viatris
VTRS
|
$171M |
| 2 |
Gilead Sciences
GILD
|
$125M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$96.4M |
| 4 |
Puma Biotechnology
PBYI
|
$81.8M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$73.4M |
Top Sells
| 1 |
Molina Healthcare
MOH
|
$160M |
| 2 |
SHPG
Shire pic
SHPG
|
$84.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$73.6M |
| 4 |
McKesson
MCK
|
$69.2M |
| 5 |
Illumina
ILMN
|
$52.6M |
Sector Composition
| 1 | Healthcare | 90.59% |
| 2 | Financials | 0.18% |
| 3 | Technology | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Xencor
XNCR
$591M
| $16.2M | 0.15% |
1,107,022
-23,000
| -2% | -$336K |
|
77
BioMarin Pharmaceuticals
BMRN
$11.3B
| $15.6M | 0.14% |
149,000
-39,000
| -21% | -$4.09M |
|
|
SVA
78
DELISTED
Sinovac Biotech, Ltd
SVA
| $15.3M | 0.14% |
2,667,500
| – | – |
|
79
Zimmer Biomet
ZBH
$20.7B
| $15.1M | 0.14% |
146,800
-65,500
| -31% | -$6.72M |
|
80
Galapagos
GLPG
$2.05B
| $14.5M | 0.13% |
230,000
-282,900
| -55% | -$17.8M |
|
81
Natera
NTRA
$22.8B
| $13.8M | 0.12% |
1,276,190
| – | – |
|
82
Cardinal Health
CAH
$35.8B
| $13M | 0.12% |
146,000
| – | – |
|
83
eHealth
EHTH
$123M
| $13M | 0.12% |
1,300,000
| – | – |
|
|
SGYP
84
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $12.9M | 0.12% |
2,276,648
| – | – |
|
85
Jazz Pharmaceuticals
JAZZ
$7.94B
| $12.7M | 0.11% |
90,000
-25,000
| -22% | -$3.51M |
|
|
NBRV
86
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $12.7M | 0.11% |
1,315,000
| – | – |
|
|
IMMU
87
DELISTED
Immunomedics Inc
IMMU
| $11.7M | 0.11% |
3,802,000
+479,000
| +14% | +$1.47M |
|
88
The Ensign Group
ENSG
$9.89B
| $11.2M | 0.1% |
495,200
+247,600
| +100% | +$5.6M |
|
|
BXLT
89
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $11.1M | 0.1% |
285,000
| – | – |
|
|
CLLS
90
Cellectis
CLLS
$263M
| $10.9M | 0.1% |
350,000
| – | – |
|
91
Assembly Biosciences
ASMB
$183M
| $10.5M | 0.1% |
1,397,100
| – | – |
|
92
MacroGenics
MGNX
$118M
| $9.82M | 0.09% |
317,000
| – | – |
|
93
Abbott
ABT
$228B
| $9.48M | 0.09% |
211,000
| – | – |
|
|
VTAE
94
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $8.82M | 0.08% |
487,400
+125,900
| +35% | +$2.28M |
|
|
SIEN
95
DELISTED
Sientra, Inc.
SIEN
| $8.04M | 0.07% |
1,357,500
-1,622,500
| -54% | -$9.6M |
|
96
Iovance Biotherapeutics
IOVA
$800M
| $7.89M | 0.07% |
1,022,100
| – | – |
|
|
MDVN
97
DELISTED
MEDIVATION, INC.
MDVN
| $7.88M | 0.07% |
+163,000
| New | +$7.88M |
|
|
MRNS
98
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $7.37M | 0.07% |
+965,000
| New | +$7.37M |
|
|
RDHL
99
Redhill Biopharma
RDHL
$2.94M
| $7.28M | 0.07% |
564,900
| – | – |
|
|
AET
100
DELISTED
Aetna Inc
AET
| $7.24M | 0.07% |
67,000
| – | – |
|